REFRACTORY VISUAL PATHWAY GLIOMA

Clinical trials for REFRACTORY VISUAL PATHWAY GLIOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY VISUAL PATHWAY GLIOMA trials appear

Sign up with your email to follow new studies for REFRACTORY VISUAL PATHWAY GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for kids with Tough-to-Treat brain tumors

Disease control Ongoing

This study tested a drug called selumetinib for children and young adults whose low-grade brain tumors have returned or stopped responding to treatment. The goal was to find a safe dose and see if the drug could shrink or control the tumors. Participants took the drug orally in r…

Matched conditions: REFRACTORY VISUAL PATHWAY GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

REFRACTORY VISUAL PATHWAY GLIOMA

Get alerted when new REFRACTORY VISUAL PATHWAY GLIOMA trials appear

New hope for kids with Tough-to-Treat brain tumors